OTCQB
MSSTF

Mindset Pharma Inc

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Mindset Pharma Inc Stock Price

Vitals

Today's Low:
$0.5353
Today's High:
$0.5375
Open Price:
$0.5353
52W Low:
$0.1626
52W High:
$0.5495
Prev. Close:
$0.541
Volume:
1000

Company Statistics

Market Cap.:
$53.59 million
Book Value:
-0.021
Revenue TTM:
$7.75 million
Operating Margin TTM:
-69.82%
Gross Profit TTM:
$3.91 million
Profit Margin:
-78.82%
Return on Assets TTM:
-32.36%
Return on Equity TTM:
-471.07%

Company Profile

Mindset Pharma Inc had its IPO on under the ticker symbol MSSTF.

The company operates in the Healthcare sector and Biotechnology industry. Mindset Pharma Inc has a staff strength of 0 employees.

Stock update

Shares of Mindset Pharma Inc opened at $0.54 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.54 - $0.54, and closed at $0.54.

This is a -0.65% slip from the previous day's closing price.

A total volume of 1,000 shares were traded at the close of the day’s session.

In the last one week, shares of Mindset Pharma Inc have increased by +1.43%.

Mindset Pharma Inc's Key Ratios

Mindset Pharma Inc has a market cap of $53.59 million, indicating a price to book ratio of 28.8748 and a price to sales ratio of 4.8286.

In the last 12-months Mindset Pharma Inc’s revenue was $7.75 million with a gross profit of $3.91 million and an EBITDA of $0. The EBITDA ratio measures Mindset Pharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Mindset Pharma Inc’s operating margin was -69.82% while its return on assets stood at -32.36% with a return of equity of -471.07%.

In Q1, Mindset Pharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 16.6%.

Mindset Pharma Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Mindset Pharma Inc’s profitability.

Mindset Pharma Inc stock is trading at a EV to sales ratio of 3.4157 and a EV to EBITDA ratio of -2.0982. Its price to sales ratio in the trailing 12-months stood at 4.8286.

Mindset Pharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$8.71 million
Total Liabilities
$10.76 million
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Mindset Pharma Inc ended 2024 with $8.71 million in total assets and $0 in total liabilities. Its intangible assets were valued at $8.71 million while shareholder equity stood at $-2150070.00.

Mindset Pharma Inc ended 2024 with $0 in deferred long-term liabilities, $10.76 million in other current liabilities, in common stock, $-32616249.00 in retained earnings and $0 in goodwill. Its cash balance stood at $7.25 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Mindset Pharma Inc’s total current assets stands at $8.59 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.08 million and inventory worth $0.

In 2024, Mindset Pharma Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Mindset Pharma Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.54
52-Week High
$0.5495
52-Week Low
$0.1626
Analyst Target Price
$

Mindset Pharma Inc stock is currently trading at $0.54 per share. It touched a 52-week high of $0.5495 and a 52-week low of $0.5495. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.43 and 200-day moving average was $0.28 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 957.6% of the company’s stock are held by insiders while 7.4% are held by institutions.

Frequently Asked Questions About Mindset Pharma Inc

The stock symbol (also called stock or share ticker) of Mindset Pharma Inc is MSSTF

The IPO of Mindset Pharma Inc took place on

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$29.58
0.89
+3.1%
$2.56
-0.29
-10.18%
$2.61
0.18
+7.41%
$110.13
1.03
+0.94%
$77.82
0.02
+0.03%
$1024.85
9.7
+0.96%
3M Company (MMM)
$107.16
-0.73
-0.68%
$3.82
0.18
+4.95%
$123.15
-4
-3.15%
$47.63
-0.04
-0.08%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.

Address

217 Queen Street West, Toronto, ON, Canada, M5V 0R2